
Prescription Required

Authentic Product

India's Leading Generic Pharmacy

Secure Payment
HERTRAZ 150MG INJECTION
HERTRAZ 150MG INJECTION
By MYLAN PHARMACEUTICALS PRIVATE LIMITED
MRP
₹
19500
₹8585
55.97 % OFF
Check Delivery
--

Composition
Product Details
About HERTRAZ 150MG INJECTION
- HERTRAZ 150MG INJECTION contains Trastuzumab as its active ingredient and is prescribed for HER2-positive breast cancer. In these patients, breast cancer cells exhibit an abundance of HER2 proteins, which accelerate tumor growth by signaling the cancerous cells to multiply rapidly. This medication is also indicated in cases of metastatic gastric cancer where there are elevated levels of HER2 proteins.
- HER2-positive breast cancers are often aggressive. Targeted therapies, like HERTRAZ 150MG INJECTION, work by selectively targeting the HER2 proteins that fuel cancer's growth, development, and spread. It is crucial to use effective contraception during treatment and for at least seven months following the final dose of HERTRAZ 150MG INJECTION to prevent potential harm to a developing fetus. This drug binds to the HER2 receptor, blocking signals that tell the cancer cells to grow and divide.
- Before starting HERTRAZ 150MG INJECTION, discuss your complete medical history with your doctor. This medication is generally not recommended for patients under 18 years of age or those with severe respiratory issues requiring oxygen therapy. Inform your physician about any pre-existing heart conditions, breathlessness, or previous cancer treatments you have received. Provide a comprehensive list of all medications you are currently taking, including prescription drugs, over-the-counter medications, dietary supplements, and herbal remedies.
- HERTRAZ 150MG INJECTION is administered intravenously, usually over a period of 30 to 90 minutes. The dosage and frequency of administration will be determined by your doctor based on your individual needs and response to treatment. It's important to adhere to the prescribed schedule and attend all scheduled appointments. During treatment, you may experience side effects such as fever, chills, nausea, vomiting, diarrhea, headache, fatigue, weakness, or skin rash. If any of these side effects become severe or persistent, notify your doctor immediately.
- Regular monitoring of heart function is essential during treatment with HERTRAZ 150MG INJECTION, as it can potentially cause heart problems. Your doctor will conduct tests to assess your heart's health before, during, and after treatment. It is vital to promptly report any symptoms of heart problems, such as chest pain, shortness of breath, swelling of the ankles or legs, or rapid weight gain. Lifestyle modifications, such as maintaining a healthy weight, eating a balanced diet, and avoiding smoking, can help reduce the risk of heart problems during treatment.
Uses of HERTRAZ 150MG INJECTION
- HERTRAZ 150MG INJECTION is indicated for its use in the following conditions:
- Advanced and metastatic breast cancer.
- Metastatic gastric cancer.
Side Effects of HERTRAZ 150MG INJECTION
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Serious side effects include heart problems, allergic reactions, kidney problems, and breathing difficulties. Common side effects include fever, visual disturbances, nose bleeds or runny nose, hair loss, dizziness, nail disorders, weight loss, loss of appetite, bruising, dry mouth, liver inflammation, muscle pain, and asthma/lung disorders.
- Heart Problems
- Allergic reactions
- Kidney problems
- Breathing difficulties
- Fever
- Visual disturbances
- Nose bleeds or runny nose
- Hair loss
- Dizziness
- Nail disorders
- Weight loss
- Loss of appetite
- Bruising
- Dry mouth
- Liver inflammation
- Muscle pain
- Asthma/ lung disorders
Safety Advice for HERTRAZ 150MG INJECTION

Pregnancy
UNSAFEDiscuss with your physician before taking this HERTRAZ 150MG INJECTION if you are pregnant or think you might be pregnant. Do not take this medicine during the pregnancy unless advised by the doctor to take as it may cause to the unborn baby.
Dosage of HERTRAZ 150MG INJECTION
- HERTRAZ 150MG INJECTION is administered either before or after surgery, depending on your specific treatment plan as determined by your healthcare provider. The timing will be carefully considered to maximize the effectiveness of the treatment.
- The initial dose of HERTRAZ 150MG INJECTION is administered intravenously over a period of 90 minutes. During this initial infusion, you will be closely monitored for any signs of adverse reactions or infusion-related symptoms. If the 90-minute infusion is well-tolerated without any significant issues, subsequent doses can be administered over a shorter period of 30 minutes. This allows for a more convenient and efficient administration process, while still ensuring your safety and well-being. Your healthcare team will continuously assess your response to the treatment and adjust the infusion duration accordingly. Close monitoring during and after each infusion is crucial to detect and manage any potential side effects promptly.
- It's important to follow your doctor's instructions precisely regarding the administration of HERTRAZ 150MG INJECTION. Do not attempt to self-administer the medication or alter the infusion schedule without consulting your healthcare provider.
How to store HERTRAZ 150MG INJECTION?
- Keep HERTRAZ 150MG INJ away from the reach of children and pets.
- Store HERTRAZ 150MG INJ in a refrigerator (2 - 8°C). Do not freeze.
Benefits of HERTRAZ 150MG INJECTION
- HER2, or human epidermal growth factor receptor 2, is a protein that, when overexpressed on the surface of certain cancer cells, fuels their uncontrolled growth. These elevated levels of HER2 act as a signal, constantly telling the cancer cells to divide and multiply rapidly. HERTRAZ 150MG INJECTION is a targeted therapy designed to specifically address this issue. It works by selectively binding to the HER2 protein on the surface of these cancer cells. This binding action effectively blocks the HER2 receptor, preventing it from sending growth signals to the cancer cell. By disrupting this signaling pathway, HERTRAZ 150MG INJECTION helps to slow down or even stop the growth and spread of cancer cells that overexpress HER2. This targeted approach minimizes damage to healthy cells, reducing overall side effects compared to traditional chemotherapy.
- By blocking HER2, HERTRAZ 150MG INJECTION deprives cancer cells of a crucial growth signal.
- This targeted action helps to slow or stop cancer growth with potentially fewer side effects.
- HERTRAZ 150MG INJECTION offers a focused treatment option for cancers that rely on HER2 for growth.
How to use HERTRAZ 150MG INJECTION
- HERTRAZ 150MG INJECTION is typically administered under the supervision of a healthcare professional, either before or after surgery, depending on the specific treatment plan. This medication is delivered intravenously, meaning it's given directly into a vein. The initial infusion usually takes around 90 minutes to allow the medical team to monitor for any potential reactions or side effects. During this first infusion, close observation is crucial to ensure the patient tolerates the medication well.
- If the initial 90-minute infusion is well-tolerated without significant adverse reactions, subsequent doses of HERTRAZ 150MG INJECTION can be administered over a shorter period, typically around 30 minutes. This expedited infusion time can make the treatment process more convenient for the patient. However, the decision to shorten the infusion duration always rests with the healthcare provider, based on their assessment of the patient's individual response and tolerance to the medication.
- It's essential to adhere to the prescribed dosage and administration schedule provided by your doctor or healthcare team. Do not attempt to self-administer this medication. If you have any concerns or experience any unusual symptoms during or after the infusion, inform your healthcare provider immediately.
FAQs
Is HERTRAZ 150MG INJECTION used as a monotherapy in treating breast cancer?

HERTRAZ 150MG INJECTION is generally given along with the chemotherapy medication such as paclitaxel or docetaxel or platinum compunds. Sometimes, it is also given with hormonal agents for those patients with elevated hormonal status.
Does HERTRAZ 150MG INJECTION cause heart problems?

Yes, HERTRAZ 150MG INJECTION can damage the heart muscles. Hence to prevent the worsening of symptoms, it is advised to do heart check up every 3 months and continue till 2-5 years after the treatment completion.
Can I breastfeed while on treatment with HERTRAZ 150MG INJECTION?

No, since tends to pass into breast milk, it is unsafe to breastfeed. Hence, It is advised not to breastfeed for a minimum of 7 months after the treatment with HERTRAZ 150MG INJECTION.
Can HERTRAZ 150MG INJECTION be consumed during pregnancy?

No, it is unsafe to consume HERTRAZ 150MG INJECTION while you are pregnant or this medicine can cause harm to the baby by reducing the amount of amniotic fluid,the fluid surrounding the womb. It can also cause organ developmental issues such as poor lung development when consumed during pregnancy. If you are planning for pregnancy, it is advised to discuss the birth control methods as this medicine may impair your fertility.
Does HERTRAZ 150MG INJECTION interact with other drugs?

There is no known interaction of HERTRAZ 150MG INJECTION with other drugs.
What advice should I follow while taking HERTRAZ 150MG INJECTION?

It is suggested to inform your doctor if you have a history of allergic reactions to HERTRAZ 150MG INJECTION to avoid life-threatening complications. If you have a history of lung disorder or breathing problems inform your doctor beforehand before the treatment commencement. Avoid planning for pregnancy and breastfeeding for a minimum of 7 months after the last dose. Monitor your heart parameters regularly during the treatment with HERTRAZ 150MG INJECTION as it may impact the functioning of heart.
What molecule/combination is used for making HERTRAZ 150MG INJECTION?

TRASTUZUMAB is molecule/combination used for making HERTRAZ 150MG INJECTION.
For what ailments/diseases/conditions is HERTRAZ 150MG INJECTION prescribed?

HERTRAZ 150MG INJECTION is prescribed for ailments/diseases/conditions related to Oncology.
Ratings & Review
वेरी गुड एक्सीलेंट
bhavtosh vyas
•
Reviewed on 31-01-2024
(5/5)
Very good service and discount
Yatin Patel
•
Reviewed on 13-01-2024
(5/5)
Service and prize is good
Bhavin Shah
•
Reviewed on 13-04-2024
(5/5)
Best service always... Best staff ..thank u being over life part
Nisha Khan
•
Reviewed on 01-07-2023
(5/5)
(Translated by Google) This is the right medkart for generics. (Original) Generic ke liye ye sahi hai medkart
Pravas Ranjan Acharya
•
Reviewed on 24-05-2023
(2/5)
Marketer / Manufacturer Details
MYLAN PHARMACEUTICALS PRIVATE LIMITED
Country of Origin -
India
Alternatives
Customer Also Bought

MRP
₹
19500
₹8585
55.97 % OFF
Quick Links
Related Blogs
Disclaimer
Medkart's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, medicines, generic alternatives, all possible side effects, drug interactions, warnings, alerts, lab tests, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.
India's most trusted generic medicine pharmacy.
10 Lakh+
Happy customers
35000+
Pin-codes Covered
75 Lakh+
Orders Delivered

Authentic Products
All WHO-GMP Certified Medicines
About Medkart Pharmacy
Our Services
Download the app for free
©2025 Medkart Pharmacy. All Rights Reserved